Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Helicobacter pylori is strongly associated to the development of gastrointestinal disorders. Emerging antibiotic resistance and poor patient compliance of modern therapies has resulted in significant eradication failure. Clinical trial was conducted to see the efficacy of current quadruple and phytomedicine-based therapies for the eradication of H. pylori infection and relief in its associated symptoms in Pakistan.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hafiz Muhammad Asif
• Treatments: Amoxicillin; Bismuth; Bismuth tripotassium dicitrate; Ranitidine; Ranitidine bismuth citrate

Criteria

Inclusion Criteria:

1. The patients suffering from H. pylori infection

2. Patients having no previous record of treatment against H. pylori infection

3. Patients living in Karachi, Rawalpindi and Bahawalpur

4. Patients having no pathological complications on routine examination

5. All socioeconomic classes were included in the study

6. Male and female patients between 15 to 45 years of age

Exclusion Criteria:

1. there was peptic ulceration, gastrointestinal bleeding or gastric carcinoma

2. if history of use of antibiotics, proton-pump inhibitors or bismuth compound in the last one month before test

3. any patient found to be allergic or intolerant to therapeutic regimens

4. they failed to report for follow-up